SpagsCorp Sets the Stage for a Groundbreaking New Chapter in Life Sciences Backed By Two Decades of Success and Innovative Solutions

Jay Spagnuolo “Spags”

In an exciting development, SpagsCorp Consulting Inc. is proud to announce its recent rebranding, marking a transformative moment for the company as it continues to prove itself as a leading force in delivering cutting-edge solutions within the Life Sciences sector.

Founded in 2001 by Jay Spagnuolo—an accomplished electrical engineer and entrepreneur who helped lead the groundbreaking IQVIA Study Hub initiative, the technology platform that played a pivotal role in accelerating the development of the COVID vaccine—SpagsCorp is a powerhouse in the Life Sciences industry. Focusing on diverse domains such as Cell & Gene Therapy System Development, Chain of Identity and Chain of Custody, Clinical Trial Management System Development, and Pharmacovigilance, SpagsCorp stands at the forefront of technological advancement.

With an ethos rooted in a commitment to excellence and innovation, SpagsCorp leverages its extensive experience in enterprise software implementation, including but not limited to Salesforce and SAP solutions, to bring a unique blend of technical expertise and industry insight to help companies go to market with clinical and commercial solutions for their businesses.